Zidovudine

Revision as of 18:09, 9 January 2014 by ShiSheng (talk | contribs)
Jump to navigation Jump to search
Zidovudine
RETROVIR® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

For patient information about Zidovudine Injection, click here.
For patient information about Zidovudine Oral, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Zidovudine (INN) or azidothymidine (AZT) (also called ZDV) is an antiretroviral drug, the first approved for treatment of HIV. It is also sold under the names Retrovir® and Retrovis®, and as an ingredient in Combivir® andTrizivir®. It is an analog of thymidine.

Category

Antiretroviral

US Brand Names

RETROVIR®

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages

Mechanism of Action

References